Please login to the form below
clinical benefit
This page shows the latest clinical benefit news and features for those working in and with pharma, biotech and healthcare.
Latest news
-
FDA starts speedy review of Lynparza plus Avastin in ovarian cancer
its formulation of fish oil-derived omega-3 carboxylic acids – in mixed dyslipidaemia because it was unlikely to show a clinical benefit on cardiovascular outcomes.
-
Apellis jumps as pegcetacoplan tops Alexion’s Soliris in PNH trial
approval. Much will hinge on whether the FDA will accept a rise in haemoglobin levels as sufficient evidence of clinical benefit on its own, or as is likely will need to
-
NICE rejects Akcea’s rare inherited disorder drug Waylivra
Although NICE did not raise any concerns about Waylivra’s safety, it did take issue with it long-term clinical benefit, as well as its steep price. ... Despite acknowledging that clinical trials of the drug demonstrated some benefit in the short-term,
-
AbbVie’s JAK inhibitor Rinvoq approved in EU for rheumatoid arthritis
Low disease activity and clinical remission rates were consistent across the patient populations. ... marginal clinical benefit’ over Humira, but with a more costly price tag.
-
FDA grants surprise OK to Sarepta’s DMD therapy after earlier rejection
The FDA now says that Vyondys 53 (golodirsen) is “reasonably likely” to have a clinical benefit in DMD and that its decision takes into account “the potential risks associated with the ... Use of the accelerated approval pathway will make Vyondys
More from news
Approximately 1 fully matching, plus 156 partially matching documents found.
Latest Intelligence
-
Novel endpoints in the digital age
Every clinical trial has an endpoint, a measure used to determine if the drug in question provides therapeutic benefit. ... measure safety, efficacy and clinical benefit of a medicine in a trial.
-
The European Medicines Agency: PRIME’d for access?
The scheme. The PRIME scheme is for medicines that have real promise, defined by the EMA as medicines that may offer a major therapeutic advantage over existing treatments, or benefit patients ... Companies who want to benefit from the scheme have to
-
Can new data aggregators shift the balance of power away from pharma?
This could have far-reaching consequences for some players in the pharmaceutical industry who may find their product pricing to be untenable when the cost/clinical benefit calculus becomes totally transparent.
-
Patient recruitment and engagement standards
And the reality: 50% of clinical research sites don’t recruit a single patient. ... A number of studies have revealed that awareness changes patients’ perceptions about clinical trials, enrolment and the risk/benefit ratio of getting involved.
-
Taking a lean and careful approach
Chemotherapy and Pharmacology, which concluded its treatment regimen showed ‘encouraging clinical benefit’. ... Clinical trials. The company is moving cautiously and set its clinical trials in Israel, Italy, Turkey and Greece.
More from intelligence
Approximately 0 fully matching, plus 24 partially matching documents found.
Latest appointments
-
Dr Irina Antonijevic joins vasopharm
In this role, Dr Antonijevic will be responsible for advancing the clinical development of the cerebrovascular specialist's lead orphan drug candidate, VAS203. ... Not only will we benefit from her clinical capabilities in our ongoing pivotal study of
-
ICON's CEO named chair of ACRO
Trade body for clinical research organisation elects Ciaran Murray. The global trade body for clinical research organisations has elected ICON's CEO Ciaran Murray as chairman. ... I look forward to continuing the work that ACRO has done in promoting our
-
Industry veteran Louis Nisbet joins Sygnature board
The UK-based clinical research organisation (CRO) will benefit from Dr Nisbet's extensive experience in the life sciences industry, which includes spells in research at Roche, Glaxo and SmithKline.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
How do companies prepare for reimbursement?
The same applies to many more therapeutic areas. Moreover, even when a substantial clinical benefit is proven, payers will tend to position the product in second line, to be used when ... In some cases, for instance, when it will be essential to show
-
Are you using Patient-Reported Outcomes (PROs) in your oncology trials? If not, why not?
A recent blog, published by Sarah Tressel Gary and Rinah Yamamoto called “Patient-Reported Outcome Data in Oncology Trials - Part 2: Clinical Benefit and Patient Preference”, has sparked our interest. ... assessing the clinical benefit of oncology
-
WHITE PAPER: Patient nonadherence – the $637bn paradox
study[13] the benefit common to both was a 50% reduction in mortality risk. ... Most apparent may be the monetary cost of medicines which, through nonadherence, are wasted and don’t lead to their intended clinical benefit.
-
RWE Blog 2: Payers use real-world data cautiously
uncertainties about the criteria to identify the population of patients most likely to benefit from the product in clinical practice. ... the product hasn’t been studied in the normal combination. selected patients didn’t include the frail ones, so
-
The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
In 2018, The WHO Cancer Medicines Working Group (CMWG) adopted the European Society for Medical Oncology‒Magnitude of Clinical Benefit Scale (ESMO–MCBS) as a screening tool to identify cancer treatments ... Genentech’s Perjeta (pertuzumab). due to
More from PMHub
Approximately 0 fully matching, plus 15 partially matching documents found.
Featured jobs
-
Account Director, Medical Education
-
Salary TBC
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
-
Scientific Director
-
£60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more
-
Publications director
-
Competitive salary and bonus scheme
- Account Director, Healthcare Communications
-
Salary TBC
-
Account Manager (PR)
-
Great Benefits
-
Senior External Communications Lead
-
£Competitive Salary
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Director
-
£Competitive Salary
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Experienced medical editor
-
Competitive salary and bonus scheme
-
Account Manager
-
£Competitive Salary
-
Account director
-
Competitive salary and bonus scheme
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
Subscribe to our email news alerts
- Novo Nordisk awakens its ‘Sleeping Beauty’
- Merck KGaA divests allergy business to Dermapharm
- US backs Sanofi’s ‘fast-track’ coronavirus vaccine
- Genital herpes vaccine candidate heads for human studies
- Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
- Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
- Introducing Nucleus POLAR™, a state-of-the-art external expert search engine and engagement management tool
- GSK pays $50m upfront to tap Immatics’ cell therapy platform
- Researchers discover new antibiotic using AI
- Bedrock Group celebrates a trio of new hires
- Tocagen merges with Forte Biosciences after brain cancer fail
- Immutep spikes on trial of its LAG-3 drug with Keytruda
PMHub
Bedrock Group
Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...
Latest intelligence
- Novo Nordisk awakens its ‘Sleeping Beauty’
- Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
- How will the Tories’ historic win shape the NHS?
- Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
- CSR 'Christmas Spirit' 2019
- OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...
Quick links
Infographics
